Cetera Investment Advisers Boosts Holdings in Maximus, Inc. $MMS

Cetera Investment Advisers boosted its position in shares of Maximus, Inc. (NYSE:MMS) by 5.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,519 shares of the health services provider’s stock after acquiring an additional 247 shares during the period. Cetera Investment Advisers’ holdings in Maximus were worth $308,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Mackenzie Financial Corp lifted its position in Maximus by 2.0% during the fourth quarter. Mackenzie Financial Corp now owns 2,782,150 shares of the health services provider’s stock valued at $207,687,000 after acquiring an additional 55,583 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Maximus by 14.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider’s stock valued at $105,001,000 after purchasing an additional 177,075 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its stake in Maximus by 7.4% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider’s stock valued at $92,188,000 after purchasing an additional 84,835 shares in the last quarter. Janus Henderson Group PLC increased its stake in Maximus by 2.0% during the 4th quarter. Janus Henderson Group PLC now owns 1,186,150 shares of the health services provider’s stock valued at $88,546,000 after purchasing an additional 22,711 shares in the last quarter. Finally, Reinhart Partners LLC. increased its stake in Maximus by 65.4% during the 1st quarter. Reinhart Partners LLC. now owns 911,511 shares of the health services provider’s stock valued at $62,156,000 after purchasing an additional 360,365 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Thursday, May 15th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $90.00.

Maximus Stock Down 0.2%

MMS stock opened at $84.9250 on Wednesday. The firm has a market cap of $4.79 billion, a PE ratio of 15.64 and a beta of 0.60. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. The firm’s fifty day moving average is $73.58 and its 200 day moving average is $70.83. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.94.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.39 by $0.77. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm’s revenue was up 2.5% on a year-over-year basis. During the same quarter last year, the business earned $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.4%. The ex-dividend date is Friday, August 15th. Maximus’s dividend payout ratio (DPR) is currently 22.10%.

Insider Buying and Selling

In related news, Director Gayathri Rajan sold 7,913 shares of the firm’s stock in a transaction on Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the sale, the director owned 14,205 shares in the company, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.60% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.